- Bacteremia in Hematopoietic Stem Cell Recipients Receiving Fluoroquinolone Prophylaxis: Incidence, Resistance, and Risk Factors
-
Eryilmaz-Eren E, Izci F, Ture Z, Sagiroglu P, Kaynar L, Ulu-Kilic A
- KMID: 2534157
- Infect Chemother.
- 2022 Sep;54(3):446-455.
- doi: 10.3947/ic.2022.0005
Background: Bacteremia is a common complication in hematopoietic stem cell transplant (HSCT) recipients. Prophylactic fluoroquinolone is recommended and used in these individuals. Breakthrough infections can occur with fluoroquinolone-resistant strains. We aimed... -
- CITED
-
- Close
- SHARE
-
- Close
